Health technology assessment (HTA) and value assessment frameworks can serve as resources for determining the value of pharmaceuticals and other health interventions. To improve value assessments and their application to formulary decision making, AMCP convened key stakeholders in managed care and focused on three main objectives:
A key theme was that increasing value through innovative novel pharmaceutical product coupled with more complete data results should be recognized. However, defining value may vary based on perspective. While utilizing value assessments is one part of determining coverage and reimbursement, coverage decision makers advocated that more value assessments are needed from trusted resources. Participants also identified best practices to continue improvement of current value assessment tools and processes. Several areas noted for improvement include more robust data collection, analytical systems, and increased education on value assessment tools and frameworks across the health care industry.
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
